共 225 条
- [1] Siegel RL(2021)Cancer Statistics, 2021 CA Cancer J Clin 71 7-33
- [2] Miller KD(2019)Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019 Ann Oncol 30 1541-1557
- [3] Fuchs HE(2021)Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 Ann Oncol 32 1216-1235
- [4] Jemal A(2022)A comparative study of the triglycerides/HDL ratio and pseudocholinesterase levels in patients with bladder cancer Diagnostics (Basel) 12 431-141
- [5] Burstein HJ(2020)Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities Nat Metab 2 132-157
- [6] Curigliano G(2021)LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies Semin Cancer Biol 73 134-177
- [7] Loibl S(2021)HDL and cancer—causality still needs to be confirmed? Update 2020 Semin Cancer Biol 73 169-1962
- [8] Dubsky P(2020)Apolipoproteins, as the carrier proteins for lipids, are involved in the development of breast cancer Clin Transl Oncol 22 1952-1093
- [9] Gnant M(2018)Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis Dis Markers 2018 1034037-231
- [10] Poortmans P(2015)Cholesterol Levels in Blood and the Risk of Prostate Cancer: A Meta-analysis of 14 Prospective Studies Cancer Epidemiol Biomarkers Prev 24 1086-40